RS50543B - Supstituisani n-cikloheksilimidazolinoni sa mch-modulatornim dejstvom - Google Patents
Supstituisani n-cikloheksilimidazolinoni sa mch-modulatornim dejstvomInfo
- Publication number
- RS50543B RS50543B RSP-2008/0082A RSP20080082A RS50543B RS 50543 B RS50543 B RS 50543B RS P20080082 A RSP20080082 A RS P20080082A RS 50543 B RS50543 B RS 50543B
- Authority
- RS
- Serbia
- Prior art keywords
- alkyl
- group
- alkoxy
- independently
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004003811A DE102004003811A1 (de) | 2004-01-25 | 2004-01-25 | Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2005/000700 WO2005070898A1 (de) | 2004-01-25 | 2005-01-25 | Substituierte n-cyclohexylimidazolinone mit mch-modulatorischer wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS50543B true RS50543B (sr) | 2010-05-07 |
Family
ID=34745115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2008/0082A RS50543B (sr) | 2004-01-25 | 2005-01-25 | Supstituisani n-cikloheksilimidazolinoni sa mch-modulatornim dejstvom |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1711473B1 (sr) |
| JP (1) | JP2007518771A (sr) |
| KR (1) | KR20060128955A (sr) |
| CN (1) | CN1934090B (sr) |
| AR (1) | AR047453A1 (sr) |
| AT (1) | ATE383342T1 (sr) |
| AU (1) | AU2005206308A1 (sr) |
| BR (1) | BRPI0507104A (sr) |
| CA (1) | CA2554233A1 (sr) |
| CY (1) | CY1107429T1 (sr) |
| DE (2) | DE102004003811A1 (sr) |
| DK (1) | DK1711473T3 (sr) |
| ES (1) | ES2297667T3 (sr) |
| HR (1) | HRP20080077T3 (sr) |
| IL (1) | IL176917A0 (sr) |
| MA (1) | MA28345A1 (sr) |
| MY (1) | MY139107A (sr) |
| NO (1) | NO20063757L (sr) |
| PE (1) | PE20051091A1 (sr) |
| PL (1) | PL1711473T3 (sr) |
| PT (1) | PT1711473E (sr) |
| RS (1) | RS50543B (sr) |
| RU (1) | RU2006130626A (sr) |
| TW (1) | TW200604182A (sr) |
| UY (1) | UY28726A1 (sr) |
| WO (1) | WO2005070898A1 (sr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1966164B1 (en) | 2005-12-21 | 2013-03-06 | Janssen Pharmaceutica N.V. | Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
| MX2009005908A (es) | 2006-12-05 | 2009-06-16 | Janssen Pharmaceutica Nv | Derivados novedosos de diaza-espiro-piridinona sustituidos para usarse en las enfermedades mediadas por la hormona concentradora de melanina 1. |
| KR100893394B1 (ko) * | 2007-05-11 | 2009-04-17 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
| TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| DE102008060967A1 (de) * | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylsulfonyltriazolone und ihre Verwendung |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
| WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| PL223830B1 (pl) | 2012-04-03 | 2016-11-30 | Univ Jagielloński | Pochodne aromatycznych imidazolidynonów i ich zastosowanie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR037621A1 (es) * | 2001-12-04 | 2004-11-17 | Schering Corp | Antagonistas de la hormona concentradora de melanina (mch), composiciones farmaceuticas, un proceso para elaborar una composicion farmaceutica y el uso de dichos compuestos, solos o en combinacion para la fabricacion de un medicamento para el tratamiento de la obesidad |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
2004
- 2004-01-25 DE DE102004003811A patent/DE102004003811A1/de not_active Withdrawn
-
2005
- 2005-01-24 AR ARP050100240A patent/AR047453A1/es not_active Application Discontinuation
- 2005-01-25 WO PCT/EP2005/000700 patent/WO2005070898A1/de active Application Filing
- 2005-01-25 CA CA002554233A patent/CA2554233A1/en not_active Abandoned
- 2005-01-25 AT AT05707002T patent/ATE383342T1/de not_active IP Right Cessation
- 2005-01-25 PT PT05707002T patent/PT1711473E/pt unknown
- 2005-01-25 RU RU2006130626/04A patent/RU2006130626A/ru not_active Application Discontinuation
- 2005-01-25 UY UY28726A patent/UY28726A1/es unknown
- 2005-01-25 TW TW094102156A patent/TW200604182A/zh unknown
- 2005-01-25 BR BRPI0507104-6A patent/BRPI0507104A/pt not_active IP Right Cessation
- 2005-01-25 PE PE2005000095A patent/PE20051091A1/es not_active Application Discontinuation
- 2005-01-25 KR KR1020067015035A patent/KR20060128955A/ko not_active Application Discontinuation
- 2005-01-25 DK DK05707002T patent/DK1711473T3/da active
- 2005-01-25 RS RSP-2008/0082A patent/RS50543B/sr unknown
- 2005-01-25 AU AU2005206308A patent/AU2005206308A1/en not_active Abandoned
- 2005-01-25 EP EP05707002A patent/EP1711473B1/de active Active
- 2005-01-25 DE DE502005002497T patent/DE502005002497D1/de active Active
- 2005-01-25 CN CN2005800091349A patent/CN1934090B/zh not_active Expired - Fee Related
- 2005-01-25 PL PL05707002T patent/PL1711473T3/pl unknown
- 2005-01-25 ES ES05707002T patent/ES2297667T3/es active Active
- 2005-01-25 MY MYPI20050274A patent/MY139107A/en unknown
- 2005-01-25 JP JP2006550073A patent/JP2007518771A/ja not_active Abandoned
-
2006
- 2006-07-17 IL IL176917A patent/IL176917A0/en not_active IP Right Cessation
- 2006-08-03 MA MA29233A patent/MA28345A1/fr unknown
- 2006-08-22 NO NO20063757A patent/NO20063757L/no not_active Application Discontinuation
-
2008
- 2008-02-22 HR HR20080077T patent/HRP20080077T3/xx unknown
- 2008-03-21 CY CY20081100322T patent/CY1107429T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1711473A1 (de) | 2006-10-18 |
| TW200604182A (en) | 2006-02-01 |
| BRPI0507104A (pt) | 2007-06-19 |
| EP1711473B1 (de) | 2008-01-09 |
| ES2297667T3 (es) | 2008-05-01 |
| KR20060128955A (ko) | 2006-12-14 |
| UY28726A1 (es) | 2005-08-31 |
| DK1711473T3 (da) | 2008-05-26 |
| RU2006130626A (ru) | 2008-02-27 |
| MY139107A (en) | 2009-08-28 |
| IL176917A0 (en) | 2006-12-10 |
| MA28345A1 (fr) | 2006-12-01 |
| NO20063757L (no) | 2006-10-11 |
| PT1711473E (pt) | 2008-03-07 |
| AR047453A1 (es) | 2006-01-18 |
| CY1107429T1 (el) | 2012-12-19 |
| PE20051091A1 (es) | 2006-01-23 |
| CA2554233A1 (en) | 2005-08-04 |
| AU2005206308A1 (en) | 2005-08-04 |
| ATE383342T1 (de) | 2008-01-15 |
| CN1934090A (zh) | 2007-03-21 |
| JP2007518771A (ja) | 2007-07-12 |
| DE502005002497D1 (de) | 2008-02-21 |
| HRP20080077T3 (en) | 2008-03-31 |
| PL1711473T3 (pl) | 2008-05-30 |
| CN1934090B (zh) | 2010-04-07 |
| DE102004003811A1 (de) | 2005-08-11 |
| WO2005070898A1 (de) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS50543B (sr) | Supstituisani n-cikloheksilimidazolinoni sa mch-modulatornim dejstvom | |
| RS53812B1 (sr) | Nova jedinjenja koja se vezuju za fxr (nr1h4) i moduliraju njegovu aktivnost | |
| HRP20070421T3 (en) | Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics | |
| RS53021B (sr) | Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi | |
| RS52702B (sr) | Jedinjenja karbazola i terapeutske upotrebe jedinjenja | |
| HRP20090266T1 (en) | Malonamide derivatives blocking the activity of gamma-secretase | |
| RS52902B (sr) | Novi piridinski derivati i pirimidinski derivati (3) | |
| RS52626B (sr) | Derivati piridizinona | |
| RS50542B (sr) | Derivati alkilpiperazin- i alkilhomopiperazin-karboksilata, postupci za njihovo dobijanje i njihova primena kao inhibitora enzima faah | |
| AR086144A1 (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
| BRPI0413991A (pt) | composto ativador de ppar e composição farmacêutica contendo o mesmo | |
| HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
| RS53682B1 (sr) | Derivati pirazinona i njihova upotreba u lečenju oboljenja pluća | |
| RS51403B (sr) | Derivati 3-ili 4-monosupstituisanih fenola i tiofenola, koji su korisni kao h3 ligandi | |
| ATE556085T1 (de) | Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna | |
| MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| RS52212B (sr) | Hidroksilovani i metoksilovani ciklopenta [d] pirimidina kao inhibitori akt proteinskih kinaza | |
| AR063804A1 (es) | Compuestos de azoniabiciclo[2.2.2]octano | |
| RS51471B (sr) | Derivati bifeniloksisirćetne kiseline za tretman bolesti dišnog trakta | |
| EA200800476A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| HRP20080311T3 (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
| HRPK20040930B3 (en) | Acyl-4-carboxyphenylurea derivatives, method for production and use thereof | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| ATE481457T1 (de) | Schwarze inkjet-tinte, tintenkombination, inkjet- aufzeichnungsverfahren, tintenpatrone, aufzeichnungsaggregat und inkjet- aufzeichnungsgerät | |
| RS50491B (sr) | Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja |